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Abstract 
The mechanism behind the cholesterol lowering effects of apple pomace, a polyphenol- and fibre rich by-product in 
apple juice production, was investigated. Groups of male F344 rats were fed a control feed or the same feed with 2.1% 
or 6.5% dry apple pomace with or without seeds for 4 weeks. Effects on plasma cholesterol concentrations, excretion of 
bile acids, expression of genes involved in cholesterol- and bile acid synthesis, and other markers related to gut health 
were investigated. We found that pomace feeding decreased total-, LDL- and IDL-cholesterol concentrations compared 
to control. Higher production of SCFA, indicating elevated caecal fermentation, and increased excretion of total- and 
primary bile acids could explain the observed hypocholesterolemic effects of apple pomace, however, expression of 
selected genes involved in cholesterol and bile acid biosynthesis (Hmgcr and Cyp7a1) were not affected. We found no 
hepatotoxic or other effects of apple seeds. Altogether, our results indicate that apple pomace has beneficial effects on 
gut health, and that the cholesterol-lowering effect is linked to increased production of SCFA and excretion of bile 
acids. These effects are most likely linked to the fibre and other fruit constituents present in the pomace. Presence of 
apple seeds seems to impart no toxicity even at 6.5% pomace in the feed and seeds also had no influence on the 
biological effect of the pomace. In the future, apple pomace could potentially be used as a bioactive and possibly health 
promoting food ingredient.  
 
Keywords CVD, lipid metabolism, functional food, dietary fibre, apple polyphenols, SCFA 
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Introduction  
Several studies report an inverse association between fruit intake and risk of CVD.1-4 Apples are among the most 
frequently eaten fruits in Europe, and apple consumption is inversely related to CVD risk.5-7 The health benefits are 
often ascribed to their content of polyphenols and dietary fibre, which are both reported to normalize undesirable lipid 
metabolism by decreasing serum cholesterol concentrations in some animal feeding experiments8-14 and human 
intervention studies.15-21 Most phenolic compounds are poorly absorbed, however in two studies by Nagasako-Akazome 
et al., supplementation with apple polyphenols resulted in decreased plasma cholesterol concentrations in mildly 
hypercholesterolemic subjects.19,20 Polyphenols reaching the colon are extensively metabolised by the colonic 
microbiota, resulting in the production of microbial metabolites, such as low molecular weight aromatic acids that are 
easily absorbed.22 The effective doses used in the two studies by Nagasako-Akazome et al. are far above what is 
realistic to obtain from a human diet and it is therefore not likely that apple polyphenols are the main responsible 
compounds for the beneficial effects in studies with whole apples or apple products. It therefore seems more likely that 
the beneficial effects of apple on plasma cholesterol concentrations are related to their high content of dietary fibre or to 
a combination effect with polyphenols or other constituents.23-25  
Several mechanisms have been proposed to explain the cholesterol-lowering effect of dietary fibre. Among these are 
decreased cholesterol uptake and increased faecal excretion of bile acids, related to the viscous properties of the soluble 
dietary fibre.26 Since bile acids are synthesised from cholesterol in the liver, this increased excretion might result in de 
novo biosynthesis of both bile acids and cholesterol in the liver. The enzyme 7-hydroxylase encoded by Cyp7a1 
catalyses the first and rate-limiting step in the classical/neutral pathway to convert cholesterol into bile acids,27 while 
HMG-CoA reductase, encoded by Hmgcr, is involved in hepatic cholesterol biosynthesis. Gut microbiota has been 
linked with lipid metabolism by affecting hepatic Cyp7a1 expression and metabolism of bile acids facilitating faecal 
excretion.28 Another proposed mechanism involves short-chain fatty acids (SCFA) produced by the intestinal 
microbiota during fermentation of the fibre. These fermentation products, which include acetate, propionate and 
butyrate, are reported to affect lipid metabolism in the liver.29 It seems plausible that more than one mechanism might 
be involved in the hypocholesterolemic effects of apples. 
Not all apples are of sufficiently high quality to be sold in the fresh market and they are therefore processed into 
different apple products, such as apple juices. As a result, large amounts of apple pomace are produced. This waste-
product is rich in polyphenols and dietary fibres, and might be a promising ingredient in the development of healthy 
consumer products.  
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The purpose of the present study was to investigate effects of apple pomace on caecal fermentation, plasma cholesterol 
concentrations, bile acid excretion and expression of genes involved in cholesterol metabolism to try to clarify the 
mechanism behind the previously reported cholesterol-lowering effect of apple pomace.12,14 We chose to include both 
standard pomace and pomace without apple seeds, since seeds are not always removed during processing and might 
have adverse effects. The low content of cyanohydrins in apple seeds might theoretically pose a health risk if apple 
pomace including seeds is consumed in large amounts.  
 
Materials and methods 
Animals and housing 
Fifty male F344 rats (4 weeks old) were obtained from Charles River (Sulzfeld, Germany). The animals were housed 
two by two in standard cages under controlled environmental conditions with temperature at 22 ± 1 °C, relative 
humidity at 55 ± 5% a 12/12 h light/dark cycle (9:00 a.m.-9:00 p.m), and air exchanged 8-10 times/h. Diets and 
acidified water (adjusted to pH 3.05 by citric acid to prevent growth of microorganisms) were provided ad libitum. 
Ethical approval was given by the Danish Animal Experiments Inspectorate (ethics authorization number 2004/561-917 
C9) and the experiment was overseen by the National Food Institute’s in-house Animal Welfare Committee for animal 
care and use. 
 
Apple pomaces  
Dried apple pomace (cultivar ‘Shampion’) was supplied from the Research Institute of Horticulture (Formerly Research 
Institute of Pomology and Floriculture), Skierniewice, Poland. Both apple pomace preparations derived from fruits 
harvested the same year. After harvest the apples were stored at normal atmosphere and + 2 oC to obtain a proper degree 
of ripening before processing. Apple pomace preparations were obtained by air drying of pomaces from standard apple 
juice processing technology close to processing in the commercial scale. One batch was air dried without processing 
and is called standard pomace. A second batch of pomace was washed with potable water to decrease stickiness, dried 
and then the seeds were removed by sieving, allowing the production of pomace without seeds. Preparations for the 
experiments were produced by gentle air drying (70 oC, 12h). Both types of pomaces were ground to maximize the 
uniformity of feeding material. 
Dry weight was determined by drying at 70 oC at 30 mbar vacuum, content of sugars and sorbitol were determined by 
EN 12630 method. Contents of total dietary fibre, total- and soluble pectin were determined according to the standard 
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AOAC Official Method 933.21 and method No. 26 of the International Federation of fruit juice producers (IFU) 
(www.ifu-fruitjuice.com). The contents of (+)-catechin, (-)-epicatechin, procyanidin B2, caffeoylquinic acid, 4-(p-
coumaroyl)-quinic acid, dihydrochalcones and quercetin glycosides were determined by HPLC according to Tsao et 
al.,30 while the procyanidins and their degree of polymerisation were determined as reported by Guyot et al.31 Contents 
of ash (NMKL 173:2005), total protein (NMKL 6:2003 modified Kjeldahl), carbohydrate (AOAC 982.14) and fat (ISO 
11085:2015) were determined by Eurofins Steins Laboratory A/S (Vejen, Denmark) according to the accredited 
methods provided in brackets.   
 
Diets and study design 
The rats were randomly assigned to one of 5 groups based on body weight. After one week of adaptation to the purified 
control diet, the rats were fed either control diet or control diet added 2.1% standard apple pomace with apple seeds or 
pomace without apple seeds, or control diet added 6.5% standard apple pomace with seeds or pomace without apple 
seeds for 4 weeks (Table 1). Contents of carbohydrates in the purified diets were adjusted according to the amount of 
apple pomace added. Feed intake was recorded daily and body weight was recorded weekly. After 4 weeks intervention, 
the rats were sacrificed by decapitation under CO2/O2 anaesthesia followed by exsanguination. Liver and caecum were 
weighed and samples from caecum content were taken for analyses of short-chain fatty acids (SCFA) and activities of 
β-glucosidase (BGL) and β-glucuronidase (GUS).  
  
Blood sampling and sample handling 
After decapitation, blood was collected in heparin-coated tubes (Becton Dickinson, Plymouth, UK) and plasma isolated 
by centrifugation (20 min, 2200 x g, 4 °C) for analyses of plasma alanine aminotransferase activity (ALAT), ferric 
reducing ability of plasma (FRAP), Trolox equivalent antioxidant capacity (TEAC) and lipoprotein cholesterol 
concentrations. Lipoproteins were separated into five fractions by single density gradient ultracentrifugation of plasma 
for 18h at 21 °C.32 Plasma samples were stored at -80 °C until analysed, while cholesterol concentrations in lipoprotein 
fractions were determined immediately after ultracentrifugation. Erythrocytes were lysed by addition of an equal 
volume of MilliQ water and stored at -80 °C. One ml of blood was collected into a PAXgene blood RNA tube for 
purification of RNA from the white blood cells (Becton Dickinson, Plymouth, UK). For each analysis, all samples were 
run in a randomised order within the same batch to minimise analytical variation.  
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Cholesterol concentrations in lipoprotein fractions and plasma ALAT activity   
Cholesterol concentrations in lipoprotein fractions and plasma ALAT enzyme activity were determined using a 
commercially available kit from Roche Diagnostics (Mannheim, Germany; catalogue no. A11A01634 and no. 
10851132, respectively). Both analyses were determined on a Roche/Hitachi 912 analyser (Roche Diagnostics).  
 
Measurement of pH and analysis of short chain fatty acid (SCFA) composition in caecal samples 
Shortly after the caecum was opened, pH was measured in the distal end of the caecum. Acetate, propionate, and 
butyrate in caecal contents were analyzed using capillary electrophoresis and indirect UV detection by a method 
modified from Westergaard et al.33 Briefly, approximately 0.1 g of caecal contents was diluted 10 times in alkaline 
buffer (0.1 M Tris, pH 8.7 with 100 μM malonic acid as internal standard), vortexed for 10 s, centrifuged (14000 x g, 10 
min, 4 °C) and the supernatant was filtered using a sterile 0.2 μm filter (Minisart). Samples were kept at –80 °C until 
analysis. Prior to analysis the samples were diluted 30 times by running buffer (0.2 mM 1,2,4-benzenetricarboxylic 
acid), 8 mM TRIS and 0.3 mM tetradecyltrimethylammonium bromide, pH 7.6). The fused silica capillary (0.75 μm, 
80.5 cm and 72 cm to detector window) purchased from Agilent (Waldbronn, Germany) was rinsed with 1 M NaOH 
before each sequence and pre-treated with water for 0.5 min, 0.1 M NaOH for 1 min and running buffer for 5 min 
before each run. Samples were injected by pressure (35 mbar, 2 s) and run at –30 kV for 12 min on a G1600A 
3DCapillary electrophoresis Instrument (Hewlett-Packard, Waldbronn, Germany). All chemicals were purchased from 
Sigma Aldrich, Steinheim, Germany. 
 
Analysis of β-glucosidase (BGL) and β-glucuronidase (GUS) in caecal samples 
Samples of caecal content (0.2 g) were homogenised in 1 mL PBS, 0.1% sodium-azide pH 7.4, and centrifuged (10000 
x g, 10 min, 4 °C). The supernatant was used to determine the activity of BGL and GUS at 37 ºC on an Automated 
Roche/Hitachi 912 Analyzer (Roche Diagnostics, Mannheim, Germany). BGL was measured by determining the rate of 
hydrolysis of the substrate p-nitrophenyl-ß-D-glucopyranoside. The amount of p-nitrophenol released was measured at 
415 nm with p-nitrophenol as standard. One unit (U) of enzyme was defined as the amount of enzyme that releases 1 
μmol of p-nitrophenol per h. GUS was assayed by determining the rate of release of phenolphthalein from 
phenolphthalein-ß-D-glucuronide at 540 nm with phenolphthalein as standard. One unit (U) of enzyme was defined as 
the amount of enzyme that releases 1 μmol of phenolphthalein from the substrate phenolphthalein-ß-D-glucuronide, per 
hour. The specific activities for both enzymes were reported as U/g caecal content with intra-day variations <1%.  
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RNA isolation and quantitative real-time PCR 
Total RNA was isolated from liver, colon and blood of the first 8 animals of the control group and the first 8 animals of 
each of the 2 pomace groups without seeds using Qiagen RNeasy Mini kit according to the protocol described by the 
manufacturer (Qiagen, Hilden, Germany). Reverse transcriptase reactions were performed using Random Hexamer and 
SuperScript™ II Reverse Transcriptase kit according to the manufacturer’s instructions (Invitrogen). Relative mRNA 
expression was quantified by Real-time PCR on an ABI 7900HT FAST System using the comparative ΔCt method 
according to ABI manual (TaqMan® Gene Expression Master Mix Protocol, Applied Biosystems, Foster City, CA). 
PCR amplification for each gene target was performed in triplicate with cDNA samples equivalent to 3 ng RNA. The 
eukaryotic 18S rRNA was used as internal normalisation standard and data were expressed as fold difference in gene 
expression relative to a calibrator. Control group samples were pooled and used as a calibrant. TaqMan® Gene 
Expression Assays used were the following: Eukaryotic 18S rRNA Endogenous Control (catalog number 4352930E); 
rat Hmgcr (catalog number Rn00695772_g1), rat Cyp7a1 (catalog number Rn00564065_m1). 
 
Faecal primary and secondary bile acids  
The concentration of bile acids in faecal samples was measured by LC/MS/MS by a modification of our previously 
published method.34 Briefly, total faeces were weighed and homogenized with 4 volumes (w/v) of water into a slurry. 
To a weighed aliquot (approx. 0.3 g) of this homogenate was added an internal standard containing the tetra-deuterated 
(D4) bile acids, D4-GCA (glycocholic acid), D4-CDOCA (chenodeoxycholic acid), D4-DOCA (deoxycholic acid), D4-
CA (cholic acid), D4-UDOCA (ursodeoxycholic acid), D4--MA (alpha-muricholic acid), D4-LCA (lithocholic acid) 
and extracted three times at 50 °C with 60% ethanol. The extract was diluted 1:8 with 0.1% formic acid and 
concentrated on an pre-activated Oasis HLB 3cc column (Waters, Milford, MA) and eluted with 800 µL 50% 
acetonitrile, 24% methanol and then with 800 µL 0.1% HCOOH in methanol. The combined eluate was evaporated to 
dryness and redissolved in 15% ACN, 30% methanol, and 0.1% formic acid giving an overall dilution factor of 2.5. 
Samples and standards were analysed on an Acquity UPLC with a TQ detector (Waters, operated in MRM mode) with a 
gradient from phase A to B over 5 min. The mobile phases were 30% methanol and 0.1% formic acid (mobile phase A) 
and 100% ACN and 0.1% formic acid (mobile phase B) at a total flow rate of 0.9 mL/min. Between run CV% for the 
internal standard (n=4) was 3.4% for 13C GCA, 6.7% for CDOCA, 7.2% for DOCA, 4.0% for CA, 5.1% for LCA, 
6.5% for -MA and 5.9% for UDOCA. The individual compounds were quantified using QuanLynx version 4.1 
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(Waters) based on the internal standards and external quality control samples. Based on the analytical results for the 
individual primary and secondary bile acids these were summed for each rat.  
 
FRAP and TEAC analyses of antioxidant activity 
Antioxidant activity in plasma was determined as FRAP as described by Benzie and Strain35 and as TEAC using the 
commercially available total antioxidant status kit Randox NX2332 (Lovmand Diagnostics, Malling, Denmark). Both 
analyses were performed on a Cobas Mira S (Triolab, Brøndby, Denmark) with CV% < 2%.  
 
Statistical analysis 
All data are presented as mean ± SD. Treatment effects were analysed using PROC GLM with treatment (control, 2.1% 
apple pomace and 6.3% apple pomace) as fixed factors, subject as random factor and +/- seeds as covariate. Data that 
could not meet the criteria of variance homogeneity and normal distribution after transformation were analyzed by non-
parametric test (Kruskal-Wallis H-test). For all tests a P value less than 0.05 was considered statistically significant. 
Pearson correlations were used to identify correlating variables. All statistical analyses were performed using SAS 
(SAS Enterprise Guide 3, SAS Institute, Cary, NC). 
 
Results  
Chemical composition of apple pomace   
The chemical composition of the apple pomaces was characterised (Table 2). Total dietary polyphenol and pectin 
contents of the standard pomace (including seeds) were 5.98 and 64.9 g/kg (39.6% water-soluble pectin), respectively. 
The main polyphenols were procyanidin B2 (degree of polymerization, DP=2) and higher procyanidins (DP>2) (totals 
69.0%), quercetin glycosides (12.6%), dihydrochalcones (8.4%) and (-)-epicatechin (7.3%).  This is in agreement with 
data obtained for commercial pomaces.35 Seedless pomace contained slightly more polyphenols (6.24 g/kg) and more 
pectin (96.5 g/kg, 21.1% water-soluble). Removal of the seeds resulted in decreased total procyanidin content (50.8%) 
and increased quercetin glycosides (33.4%) which could be explained by the increased proportion of skin in the seedless 
pomace compared to the standard pomace.  
Content of simple sugars was 301 g/kg in the standard pomace. Due to processing sugars were reduced by 61.2% to 117 
g/kg in the seedless pomace. Seed removal affected the dietary fibre content and the sum of polyphenols to a relatively 
low extent (Table 2). 
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Contents of total carbohydrate, total protein and total fat in apple pomaces differed slightly. Apple pomace including 
seeds contained 83.3%, 6.6% and 4.6% carbohydrate, protein and fat, respectively, while the content in a corresponding 
seedless pomace was 70.7% for carbohydrate, 5.0% for protein and 4.2% for fat. These composition differences lead to 
slightly lower energy contributions from the seedless pomace compared to standard pomace contributing less than 2% 
of the total dietary energy.    
 
Total food intake, body- and liver weight and plasma ALAT enzyme activity 
Data on mean feed- and water intakes per week, body- and relative liver weight, and plasma ALAT enzyme activity at 
sacrifice in the five groups is shown in Table 3. There was no difference in body weight, feed- or water intakes between 
the groups (P=0.521, P=0.641 and P=0.204, respectively), however there was a tendency towards an increased relative 
liver weight at the highest pomace dosage level compared to control (P=0.068). The presence of seeds in the pomace 
did not significantly affect any of these parameters. Plasma ALAT activity was significantly increased in the group fed 
6.5% apple pomace, however only in the group fed pomace  without seeds (P=0.001). The effect was ascribed to 
increased activity in two of the animals, and we found no other signs of liver toxic effect of the pomace or seeds (Table 
3). 
 
Caecal weight, pH, caecal GUS and BGL activities and concentrations of SCFAs 
Caecal contents weight was significantly increased in the highest dosage group compared to control (P=0.001). The 
caecal weight or relative caecal weight per se was not affected by any of the treatments (P=0.66 and P=0.91, 
respectively, data not shown). We found a tendency towards decreased caecal pH with pomace feeding (P=0.091) that 
was still only borderline significant after pooling all pomace-fed groups (P=0.067). Seeds did not affect pH values. 
Caecal GUS and BGL enzyme activities were unaffected by the treatments (P=0.697 and P=0.265, respectively) (Table 
4). Likewise, apple pomace did not affect the concentration of propionate in caecal content (P=0.151). However, there 
was a tendency towards increased concentration of acetate (P=0.064) with pomace intake and caecal butyrate 
concentration was significantly increased with increasing pomace dose (P=0.013). Inclusion of seeds did not affect the 
results (Figure 1). Total concentrations of SCFA increased significantly (P=0.045) with increased dosage level, from 
66.4 ± 19.8 in the control group, to 85.6 ± 16.1 and 84.2 ± 24.1 in groups supplemented with 2.1% (P=0.019) and 6.5% 
(P=0.029) apple pomace, respectively. There was no significant difference in total concentration of SCFAs between the 
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pomace groups (P=0.829). Total concentration of SCFAs (as well as each SCFA separately) correlated negatively with 
pH (r=-0.371, P=0.008).   
 
Plasma lipoprotein cholesterol concentrations  
Plasma total-, IDL- and LDL-cholesterol concentrations were significantly decreased by apple pomace compared to 
control. For both total- and IDL-cholesterol, the decreases were statistically significant at both dosage levels 
(P2.1%=0.0013 and P2.1%=0.021, P6.3%=0.001 and P6.3%=0.009 for total- and IDL-cholesterol respectively). LDL-
cholesterol was only significantly decreased at the highest dosage level (P=0.005). We saw no effects on HDL- and 
VLDL-cholesterol concentrations (P=0.085 and P=0.277 respectively) (Table 5). Total- and LDL-cholesterol 
concentrations in plasma correlated negatively with acetate (r=-0.345, P=0.014 and r=0.298, P=0.036, respectively) and 
butyrate concentrations (r=-0.372, P=0.008 and r=-0.331, P=0.019, respectively) measured in caecal content. 
Correlations in the same direction were seen between IDL-cholesterol and butyrate concentrations (r=-0.293, P=0.039).   
 
Faecal primary and secondary bile acids 
Feeding apple pomace resulted in significantly increased excretion of total faecal bile acids in the highest dosage group 
compared to both the control (P=0.029) and the lowest dosage group (P=0.009) (Figure 2). Dividing the bile acids into 
primary and secondary bile acids, revealed that the increase was explained by an increase in excretion of primary bile 
acids (-Ma, -Ma and -Ma) (P=0.006). Also here, the highest dosage group was significantly different from both 
control (P=0.009) and the lowest dosage group (P=0.005). We observed no significant changes in excretion of total 
(P=0.589) (Figure 3) or individual secondary bile acids (UDOCA, DOCA or LCA) (P=0.642, P=0.597 and P=0.612, 
respectively). Presence of seeds did not affect excretion of bile acids (P>0.05, data not shown).  
We also calculated the effect of apple pomace feeding on concentrations of total-, primary- and secondary bile acids in 
wet faeces (Figure 3). We found no effect on concentration of total bile acids (P=0.242) or secondary bile acids 
(P=0.934). However, there was a tendency towards increased concentrations of primary bile acids in animals fed apple 
pomace (P=0.071).     
 
Gene expression of liver Cyp7a1 and Hmgcr in liver, colon and lymphocytes  
Gene expression of Cyp7a1 did not decrease in liver with pomace feeding (P=0.478). Expression of Hmgcr in blood and 
colon was also unaffected by the treatment, even at the higher dosage level (P=0.284 and P=0.244, respectively), and 
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we observed a large variation between animals (Figure 4). The expression of Hmgcr in liver was likewise unaffected by 
pomace feeding (P=0.571). However, we found that gene expression of hepatic Hmgcr was negatively correlated to 
caecal propionate concentration (r=-0.434, P=0.034). Hmgcr gene expression measured in colon and blood correlated 
(r=0.489, P=0.015), while none of them were correlated to the expression measured in the liver.    
 
Plasma FRAP and TEAC 
Apple pomace affected plasma TEAC or FRAP values similarly (Table 6). In both cases, apple pomace resulted in a 
reduction in the values, however only FRAP was significantly decreased with apple pomace feeding (P=0.072 and 
P=0.016, for TEAC and FRAP, respectively). With FRAP, both dosage levels significantly decreased the marker, 
however, only in the groups given apple pomace including the seeds (P=0.002 and P=0.015 in the 2.1% and 6.3% 
pomace groups). In the two groups where pomace did not include seeds, there was no statistically significant effect on 
FRAP. 
 
Discussion   
Apple pomace, a waste-product from juice production, might be used as a food ingredient in the development of 
healthier food products because it is rich in dietary fibre and polyphenols which both have been linked to decreased 
plasma cholesterol concentrations. We used two qualities of pomace with and without the seed component. The process 
of removing the seeds from the pomace reduced sugars by about 61%, and with composition data from apple pomaces 
produced using the same cultivar, we estimate that seeds also contributed approx. 0.04 g fat and 0.16 g protein for each 
per cent to the feed composition leading to minimal differences in the overall energy intakes. Furthermore, we saw no 
differences in feed intake between the groups. Apple seeds contain the cyanogenic glycoside, amygdalin, that may pose 
a health risk if consumed in large amounts due to the conversion of amygdalin into hydrocyanic acid (HCN) upon 
physical processing (grinding or chewing). The content of seeds in apple pomace is about 7%36 and apple seeds contain 
up to 4 mg/g of amygdalin.37 Taking these data into consideration the exposure to amygdalin in the present study would 
be in the range 0.17-0,52 mg/d in rats fed 2.1-6,5% apple pomace, which is negligible in terms of risk. For cyanide a no 
observed adverse effect level of 0.36 mg cyanide/kg/d was reported in rats,38 corresponding to an daily intake of 6.1 mg 
amygdalin/kg/d, Assuming complete degradation of amygdalin (1 g of amygdalin releasing 59 mg HCN), this would 
correspond to a much higher intake of 6.1 mg amygdalin/kg/d compared to the present study. This is corroborated by 
literature data showing that defatted apple seeds fed to rats at a very high dose (amygdalin content of 13.1 mg/g) did not 
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exert any observable adverse effects after two weeks.39 Low nutritional quality of the apple seed protein was reported as 
the main issue in that study. In the present study, we confirmed the previously reported hypocholesterolemic effect of 
apple pomace, in that both total-, IDL- and LDL-cholesterol concentrations were decreased following apple pomace 
feeding. It has been suggested that apple pomace only has hypolipidemic effects in cholesterol fed or obese rodents.14,40 
However, we report here a cholesterol lowering effect of apple pomace in normal weight F344 rats receiving a diet with 
no added cholesterol. Aprikian et al. have shown that apple pectin and apple phenolics together have a much greater 
effect on the lipid profile than each has by themselves, suggesting that apple pomace which is rich in both, might have 
potential for commercial use as a bioactive food ingredient.11  It should be stressed that many industrial pomaces have 
been pectinase treated for clear juice production, while our current pomace was from cloudy apple juice production and 
had high contents of pectin as well as apple polyphenols. Overall, despite some minor differences in the composition of 
the pomaces with and without seeds we observed only few differences between their effects. 
Several mechanisms have been proposed to explain the cholesterol-lowering effect of apple pomace. Among these are a 
decreased cholesterol uptake and inhibition of bile acid reabsorption due to the viscous properties of the dietary fibres,41 
and suppression of hepatic cholesterol biosynthesis caused by SCFA.29 Besides the observed hypocholesterolemic 
effect, apple pomace affected several markers related to gut health. The positive effects on caecum weight and the 
increase in concentration of SCFA indicate stimulation of the intestinal microbiota most likely caused by the fibre 
present in the apple pomace. This is in line with previous findings, showing increased microbial activity leading to 
increased production of SCFA with a diet rich in apple fibres.42,43 No dose-response for SCFA concentration was 
observed indicating that the bulking effects of the fibre shown by the higher weight of caecum content is the major 
factor explaining the dose-response observed for total SCFA content with pomace dose. All three measured SCFAs 
increased with increasing pomace intake, but only butyrate reached statistical significance. Increases in butyrate 
concentrations have previously been ascribed to the microbial breakdown of insoluble cell-wall material,44 and we have 
recently reported that also apple pectin can change the microbiota of rats, favouring the population of butyrate 
producing Clostridiales,45 which could explain the higher production of butyrate with apple pomace observed in the 
present study. This product of microbial metabolism has been linked to improved gut health, being the main source of 
energy for colon epithelium cells46 and able to induce apoptosis, reduce metastasis in colon cell lines and protect from 
carcinogens by enhancing the expression of genes involved in detoxification.47 
Adding 6.5% apple pomace to the diet also resulted in increased excretion of bile acids, an increase that was due to 
higher excretion of primary bile acids. This could explain the lowered cholesterol concentrations, since stimulation of 
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bile acid biosynthesis from cholesterol would lead to a decrease in cholesterol stores. Apple dietary fibres have 
previously been reported to increase bile acid excretion.42 We also investigated the effect of apple pomace on bacterial 
activities of GUS and BGL. Lowered GUS activities have been shown to reduce toxicity of carcinogens in some 
studies,48 and increased activity might affect the risk of colon cancer negatively. Others have suggested that increased 
GUS might activate glucuronidated polyphenols, which is considered a beneficial effect.49 We observed no effect in this 
study indicating that the pomace has a different effect compared with apple pectin,45 possibly due to opposite effects of 
the polyphenols and pectin components of the pomace. 
Apple pomace stimulated caecal fermentation, resulting in increased concentrations of SCFA and increased excretion of 
primary bile acids which all might explain the cholesterol-lowering effects of apple pomace. To further investigate the 
mechanism behind these effects we measured the expression of genes involved in cholesterol (Hmgcr) and bile acid 
(Cyp7a1) biosynthesis. SCFA have possible systemic effects on lipid metabolism as they have been shown to inhibit 
liver cholesterol biosynthesis in experimental animals. The increase in bile acid excretion following interaction with 
fibre is likely to result in decreased reabsorption of bile acids into the liver. Cholesterol catabolism may thereby be 
increased on the expense of its biosynthesis.50,51 We did not see a significant effect on gene expression of the rate-
limiting step in cholesterol biosynthesis, Hmgcr, in either blood, liver or colon tissues. However, we note that the 
expressions tended to decrease so there was no indication of a compensatory increase in the hepatic or peripheral 
cholesterol biosynthesis. The lack of increase in Hmgcr might be a result of increased production of SCFA. It is 
generally believed that SCFAs exert their cholesterol-lowering effect through reduction of hepatic cholesterol 
biosynthesis.29 However, we were not able to confirm this, even though we saw decreased expression of Hmgcr in all 
tested tissues/cells. Likewise, we saw no statistically significant effect of pomace feeding on gene expression of hepatic 
Cyp7a1, encoding the rate-limiting enzyme in bile acid biosynthesis from cholesterol. Even though the expression 
tended to decrease with pomace feeding, the variations within groups were too high, so lack of power may have 
prohibited our ability with the present group size to link the cholesterol-lowering effect of apple pomace to the 
expression of the selected genes involved in biosynthesis of cholesterol and bile acids, respectively. Yet, this does not 
exclude that increased biosynthesis of bile acids at the expense of cholesterol is taking place. The regulation may be at 
the translational rather than the transcriptional level. Higher activity of cholesterol 7-hydroxylase, the enzyme encoded 
by Cyp7a1, with pectin feeding has previously been linked to higher bile acid concentrations and support the hypothesis 
that the hypocholesterolemic effect of soluble fibres such as pectin is modulated through increased synthesis and 
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therefore pool size of bile acids.52 We were not able to confirm this by determining the enzyme activity in the present 
study.  
From our results, it seems that apple pomace is able to affect both proposed mechanisms behind the cholesterol-
lowering effect of dietary fibre, involving increased production of SCFA and increased excretion of bile acids. 
However, we are not able to explain this by changes in the expression of genes involved in cholesterol and bile acid 
biosynthesis. An increase in SCFA concentrations has been reported to suppress cholesterol biosynthesis,29 while we 
would expect induction of cholesterol and bile acid biosynthesis to take place as a result of increased bile acid 
excretion. These opposite effects might explain the lack of change in the net hepatic cholesterol biosynthesis rate, as we 
report here.  
Besides its fibre content, apple pomace is a good source of polyphenols, with reported antioxidant activity in vitro. 
Dietary polyphenols, due to their antioxidant properties, might act as a protective antioxidant barrier in the gut system.53 
Dietary polyphenols are, once they reach the colon, extensively metabolised by the gut microbiota to form simple 
phenolic acids which are more readily absorbed. The presence of pectin might increase absorption as shown in mice.54 
We investigated the effect of apple pomace feeding on markers of antioxidant activity using two different methods. We 
found that apple pomace significantly decreased plasma FRAP. A high fibre diet has previously been associated with 
decreased blood uric acid concentrations compared to a less fibre-rich diet.55 Uric acid is a major contributor to FRAP, 
and recent studies have indicated that high uric acid concentrations are implicated in the development of hypertension, 
and furthermore, uric acid has been linked to risk of CVD.56 Based on this, decreases in FRAP might therefore be 
desirable. It has actually been suggested that an increased plasma antioxidant capacity expressed as FRAP could be 
regarded as a risk factor of CVD rather than a protective factor.57 Even though FRAP decreased in all pomace groups, 
the decrease was only statistically significant in the groups fed apple pomace including seeds. Why this is so is not 
clear, some component of the seeds may have a specific effect that needs to be investigated further. Not surprisingly, a 
similar negative effect of apple pomace was seen on TEAC that could likewise be explained by a decrease in uric acid 
levels. However, the effect on TEAC was not statistically significant. The results suggest that apple pomace, in spite of 
its relatively high concentration of polyphenols, decreases plasma antioxidant activity, which is probably related to the 
known effect of fibre on uric acid concentrations. If the effect is linked to uric acid concentrations, this might 
potentially reduce the risk of hypertension, and thereby risk of CVD.    
In the present study we have confirmed that apple pomace improves the lipid profile and positively affects the gut 
environment. Both effects on levels of SCFA and bile acids were observed and might be responsible for the cholesterol-
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lowering effects. However, effects on expression of the selected genes involved in cholesterol and bile acid biosynthesis 
could not explain these findings. Apple pomace might be an attractive food ingredient, based on the present results and 
results from an earlier human intervention study that we performed in healthy, normal-weight subjects.21 In that study 
we investigating the effect of whole apples, apple pomace, cloudy and clear apple juices on blood lipids and found that 
compared to clear apples juice the cholesterol-lowering effect of whole apples and apple pomace was linked to the fibre 
component. Altogether, the results indicate that apple pomace might have a health beneficial effect and that the 
presence of apple seeds does not pose any health risk.   
EFSA has set an acute reference dose (ARfD) for cyanide of 20 g/kg.38 Applying the assumptions made above 
concerning seed content in pomace, amygdalin concentration in seeds and release of cyanide from seeds, this would 
correspond to a daily intake of approximately 90 g pomace. The dose levels (2.1% and 6.5%) used in the present study 
correspond to a daily human intake of 94.5 g and 292.5 g of apple pomace, respectively, but adjusting for the difference 
in basal metabolic rate between rat and man, the dose is more comparable to the intake of ~20-60 g apple pomace which 
is within the ARfD and corresponds to about 400-1300 g whole apples (or 3-8 apples a day). The lowest dose level 
corresponds to the one used in our human study, where participants consumed 500 g apple (3-4 apples) or 22 g apple 
pomace a day. Similar mechanisms were affected in the two studies which might open for the potential use of apple 
pomace as an active and possibly health promoting food ingredient in the future assuming that other safety parameters 
such as contents of pesticides and heavy metals are within safety limits.     
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Table 1 Composition of the experimental diets  
Ingredients (g / kg feed) Control 2.1% pomace 6.5% pomace 
Na-caseinate 200 200 200 
Sucrose 100 93 78 
Cornstarch 456 446 426 
Soybean oil with ADEK vitaminsa 50 50 50 
Soybean oil 20 20 20 
Corn oil 80 80 80 
Cellulose 50 46 37 
Mineral mixtureb 32 32 32 
Vitamin mixturec 12 12 12 
Apple pomace - 21 65 
aContaining in mg/kg diet: 5000 (IU) vitamin A, 1000 (IU) vitamin D3, 50 (IU) vitamin E, 1 phylloquinine 
bContaining in mg/kg diet: 2500 Ca, 1600 P, 3600 K, 300 S, 2500 Na, 1500 Cl, 600 Mg, 34 Fe, 30 Zn, 10 Mn, 0.20 I, 
0.15 Mo, 0.15 Se, 2.5 Si, 1.0 Cr, 1.0 F, 0.5 Ni, 0.5 B, 0.1 Li, 0.1 V, 0.07 Co  
cContaining in mg/kg diet: 5 thiamin, 6 riboflavin, 8 pyridoxol, 2 folic acid, 0.3 D-biotin, 0.03 vitamin B-12, 20 
pantothenate, 2600 cholinhydrogentartrat, 400 inositol, 40 nicotinic acid, 40 p-aminobenzoic acid, 1000 methionine, 
2000 L-cystine 
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Table 2 Composition of the pomaces  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following methods were used: aIFU 61, bAnalysed at Eurofins by accredited methods, cNMKL 173:2005, dAOAC, 
eIFU 26, fAOAC 982.14, gNMKL 6:2003 modified Kjeldahl, hISO 11085:2015, imeasured by HPLC 
 as described in Materials and Methods. *Determined in a separate batch of standard and seedless pomace. 
Basic pomace parameters  Unit Standard pomace Seedless pomace 
Dry mattera % 97.5 96.3 
Ashesbc g/kg 15 17.5 
Sugars totalc, out of which: g/kg 300.6 116.6 
Sucrosec g/kg 21.8 13.6 
Glucosec g/kg 66.2 27.9 
Fructosec g/kg 212.6 75.1 
Sorbitolc g/kg 19.7 6.7 
Total dietary fibred (%) 49.9 59.0 
Total pectinse g/kg 64.9 96.5 
Water soluble pectinse g/kg 25.7 20.4 
Total carbohydratebf* g/kg 833 707 
Total proteinbg* g/kg 66 50 
Total fatbh* g/kg 46 42 
Phenolic compounds compositioni       
(+)-catechin mg/kg 42 36 
(-)-epicatechin mg/kg 439 431 
Procyanidins mg/kg 3670 2843 
degree of polymerization - 5.1 5.3 
procyanidin B2 mg/kg 458 327 
caffeoylquinic acid mg/kg 103 58 
4-(p-coumaroyl)-quinic acid mg/kg 14 6 
dihydrochalcones  (PLZ+XPL) mg/kg 503 454 
Quercetin glycosides mg/kg 754 2088 
Sum of phenolic compounds mg/kg 5983 6243 
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Table 3 Body weight, feed and water intakes, relative liver weight and plasma ALAT enzyme activity after 4 weeks feeding of control 
diet, or control diet added 2.1% or 6.5% apple pomacea 
Group   Body weight  Feed intake Water intake Relative liver weight  ALAT 
 N (g) (g/week) (g/week) (g/kg body weight) n (U/L) 
Control 10 188 ± 12 178 ± 11 195 ± 13 31.3 ± 1.0 9 103 ± 10 
2.1% pomace (-seeds) 10 188 ± 10 182 ± 13 206 ± 13 31.4 ± 0.2 9 105 ± 18 
2.1% pomace (+seeds) 10 194 ± 15 184 ± 16 212 ± 18 31.1 ± 1.3 10 96 ± 11 
2.1% pomace (both groups) 20 191 ± 13 183 ± 14 209 ± 15 31.2 ± 1.2 19 101 ± 15 
6.5% pomace (-seeds) 10 190 ± 18 190 ± 21 210 ± 19 32.3 ± 1.0 10 125b ± 20 
6.5% pomace (+seeds) 10 194 ± 11 189 ± 20 219 ± 25 31.7 ± 0.9 8 108 ± 14 
6.5% pomace (both groups) 20 192 ± 14 189 ± 20 214 ± 21 32.0 ± 1.0 18 117b ± 19 
aData are presented as mean and SD 
bStatistically significantly different from control (P<0.05) (ANOVA) 
ALAT alanine aminotransferase 
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Table 4 Caecal parameters in rats fed control diet, or control diet added 2.1% or 6.5% apple pomace for 4 weeksa 
Group 
 
 
n  
 
 
Caecum content 
 (g) 
 
Caecal pH 
 
 
Caecum SCFA 
content  
(moles) 
GUS  
(U/g caecal content) 
 
BGL  
(U/g caecal content) 
 
Control 10 1.90 ± 0.34 7.04 ± 0.41 125 ± 44 6.83 ± 2.22 8.20 ± 3.35 
2.1% pomace (-seeds) 10 1.91 ± 0.48 6.87 ± 0.17 165 ± 58 6.56 ± 2.40 8.81 ± 2.04 
2.1% pomace (+seeds) 10 1.79 ± 0.46 6.67 ± 0.28 150 ± 39 7.03 ± 2.11 11.11 ± 2.81 
2.1% pomace (both groups) 20 1.85 ± 0.46 6.77 ± 0.25 158 ± 42 6.79 ± 2.22  9.96 ± 2.67 
6.5% pomace (-seeds) 10 2.25 ± 0.35 6.76 ± 0.19 201b ± 50 7.82 ± 2.50 9.29 ± 1.99 
6.5% pomace (+seeds) 10 2.51b ± 0.52 6.86 ± 0.12 194b ± 70 8.42 ± 5.27 9.00 ± 1.56 
6.5% pomace (both groups) 20 2.38b ± 0.45 6.81 ± 0.16 198b ± 59 8.12 ± 4.03 9.14 ± 1.74 
aData are presented as mean and SD 
bStatistically significantly different from control (P<0.05) (ANOVA) 
SCFA short chain fatty acid, GUS β-glucuronidase, BGL β-glucosidase  
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Table 5 Plasma lipids in rats fed control diet, or control diet added 2.1% or 6.5% apple pomace for 4 weeksa 
Group  n Total cholesterol HDL-cholesterol LDL-cholesterol IDL-cholesterol VLDL-cholesterol 
  (mmol/L) (mmol/L) (mmol/L) (mmol/L) (mmol/L) 
Control 10 1.28 ± 0.10 0.52 ± 0.09 0.24 ± 0.08 0.16 ± 0.06 0.10 ± 0.03 
2.1% pomace (-seeds) 10 1.10 ± 0.17 0.43 ± 0.09 0.20 ± 0.08 0.13 ± 0.07 0.12 ± 0.04 
2.1% pomace (+seeds) 10 1.05 ± 0.11 0.45 ± 0.05 0.20 ± 0.04 0.10 ± 0.03 0.09 ± 0.02 
2.1% pomace (both groups) 20 1.07** ± 0.14 0.44 ± 0.07 0.20 ± 0.06 0.11* ± 0.05 0.11 ± 0.04 
6.5% pomace (-seeds) 10 1.09 ± 0.13 0.49 ± 0.09 0.17 ± 0.03 0.10 ± 0.02 0.12 ± 0.03 
6.5% pomace (+seeds) 10 1.04 ± 0.11 0.48 ± 0.08 0.17 ± 0.04 0.10 ± 0.04 0.11 ± 0.03 
6.5% pomace (both groups) 20 1.06** ± 0.12 0.49 ± 0.08 0.17** ± 0.04 0.10** ± 0.03 0.11 ± 0.03 
aData are presented as mean ± SD 
*significantly different from control (ANOVA), *P<0.05, **P<0.01 
HDL high-density lipoprotein, LDL low-density lipoprotein, IDL intermediary-density lipoprotein, VLDL very-low-density lipoprotein 
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Table 6 Plasma antioxidant activity in rats fed control diet, or control diet added 2.1% or 6.5% apple pomace for 4 
weeksa 
Group n  FRAP n  TEAC 
  (mol/L)  (mmol/L) 
Control 10 841 ± 151 10 0.47 ± 0.24 
2.1% pomace (-seeds) 10 753 ± 122 9 0.37 ± 0.11 
2.1% pomace (+seeds) 10 637c ± 66 9 0.27 ± 0.27 
2.1% pomace (both groups) 20 695 ± 113 18 0.32 ± 0.21 
6.5% pomace (-seeds) 10 768 ± 174 9 0.23 ± 0.14 
6.5% pomace (+seeds) 10 689b ± 140 8 0.46 ± 0.59 
6.5% pomace (both groups) 20 729 ± 159 17 0.34 ± 0.43 
aData are presented as mean and SD  
Statistically significantly different from control (ANOVA), bP<0.05, cP<0.01 
FRAP ferric reducing ability of plasma, TEAC trolox equivalent antioxidant capacity  
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Figure 1 Concentrations of the SCFAs acetate, propionate and butyrate in caecal content of rats fed control diet or 
control diet containing 2.1% or 6.5% apple pomace for 4 weeksa. 
  
aData are presented in moles/g caecal content as mean and SD.  
*P<0.05 (ANOVA).  
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Figure 2 24 hrs faecal excretion of total-, primary- and secondary bile acids (BA) from rats fed control diet, or control 
diet added 2.1% or 6.5% apple pomace for 4 weeksa 
 
aData are presented in nmoles/d as mean and SD  
*P<0.05 compared to control and lowest dosage group (ANOVA)  
BA bile acids 
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Figure 3 Concentration of total-, primary- and secondary bile acids (BA) in faecal samples from 
rats fed control diet, or control diet added 2.1% or 6.5% apple pomace for 4 weeksa  
 
aData are presented in moles/L faeces as mean and SD  
(ANOVA)  
BA bile acids 
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Figure 4 Gene expression of Hmgcr and Cyp7a1 in blood, liver or colon of rats fed control diet,  
or control diet added 2.1% or 6.5% apple pomace without seeds for 4 weeksa 
 
 
aData are presented as fold difference in gene expression relative to a calibrator as mean and SD (n=8 per group)  
(ANOVA) 
HMGCR HMG-CoA reductase, CYP7A1 7-hydroxylase 
 
